Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombotic Vascular Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01707394
What this trial is testing

Study to Evaluate a Single Dose of Apixaban in Pediatric Participants at Risk for a Thrombotic Disorder

Who this might be right for
Thromboembolism
Bristol-Myers Squibb 49
Not applicableUnknownNCT05744843
What this trial is testing

Structured Exercise Versus Endovascular Reconstruction in Post Thrombotic Syndrome

Who this might be right for
Post Thrombotic Syndrome
Guy's and St Thomas' NHS Foundation Trust 54
Early research (Phase 1)Study completedNCT06562985
What this trial is testing

Learn About How Safe BAY3018250 is and What Happens to it in Healthy Japanese Men and Adult Participants Aged 18 to 55 Years

Who this might be right for
Acute Venous and Arterial Thrombotic and Thromboembolic EventsHealthy Volunteers
Bayer 39
Not applicableLooking for participantsNCT07151976
What this trial is testing

Thrombus Aspiration and Pathology and OCT Study

Who this might be right for
Acute Coronary Syndrome
Fujita Health University 200
Not applicableStudy completedNCT06451484
What this trial is testing

Grade Analysis of Veins by MRI and CT in Post-Thrombotic Syndrome

Who this might be right for
Lower Limb Venous Thrombosis
University Hospital, Bordeaux 50
Not applicableStudy completedNCT02248610
What this trial is testing

Follow-up in Rivaroxaban Patients in Setting of Thromboembolism

Who this might be right for
Venous Thromboembolism
King's College Hospital NHS Trust 1,343
Testing effectiveness (Phase 2)Looking for participantsNCT06794008
What this trial is testing

BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusInflammatory MyopathySystemic Sclerosis (SSc)+6 more
Peking University People's Hospital 50
Large-scale testing (Phase 3)Study completedNCT04670432
What this trial is testing

Resolution Enhancement by a Supplemental Obstruction Lessening Venoactive Drug for Eight Weeks in Deep Vein Thrombosis

Who this might be right for
Deep Vein Thrombosis
Maastricht University Medical Center 44
Not applicableEnded earlyNCT03968276
What this trial is testing

Study of the Interest of Patients Undergoing Anti-thrombotic Treatment in a Digital Application of Therapeutic Assistance

Who this might be right for
Vascular Diseases
Fondation Hôpital Saint-Joseph 25
Not applicableStudy completedNCT02505217
What this trial is testing

Novel Biomarkers of Thrombotic Risk

Who this might be right for
Myocardial Infarction
University of Vermont 200
Not applicableLooking for participantsNCT05378308
What this trial is testing

NOACs Use in AF or VTE (SUNSHINE Registry)

Who this might be right for
Atrial FibrillationVenous ThromboembolismOral Anticoagulant
Henan Provincial People's Hospital 5,000
Large-scale testing (Phase 3)Study completedNCT00157079
What this trial is testing

Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders

Who this might be right for
Primary Immunodeficiency Diseases (PID)Immune Thrombocytopenic Purpura (ITP)Kawasaki Syndrome
Baxalta now part of Shire 61
Not applicableStudy completedNCT04769310
What this trial is testing

Advanced Cardiac Imaging To Predict Embolic Stroke On Brain MRI: A Pilot Study

Who this might be right for
Atrial FibrillationStrokeStroke, Cardiovascular+3 more
Tulane University 5
Large-scale testing (Phase 3)Looking for participantsNCT05726916
What this trial is testing

Eculizumab in Hypertensive Emergency-associated Hemolytic Uremic Syndrome

Who this might be right for
Hypertensive Emergency-associated Hemolytic Uremic Syndrome
Assistance Publique - Hôpitaux de Paris 66
Not applicableNot Yet RecruitingNCT07426107
What this trial is testing

Development and Prospective Validation of an AI Model for Prognosis in ITP Patients Undergoing Coronary Revascularization

Who this might be right for
Immune Thrombocytopenic PurpuraCoronary Artery Disease
Xiao Hui Zhang 600
Not applicableNot Yet RecruitingNCT06808607
What this trial is testing

Clinical Outcomes of Primary Versus Secondary Antiphospholipid Syndrome

Who this might be right for
Antiphospholipid Syndrome
Assiut University 52
Large-scale testing (Phase 3)Study completedNCT01225562
What this trial is testing

Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin

Who this might be right for
Myocardial InfarctionCardiovascular DeathAtherothrombosis+1 more
AstraZeneca 21,379
Post-approval studies (Phase 4)Study completedNCT02939872
What this trial is testing

Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events

Who this might be right for
Percutaneous Transluminal Coronary AngioplastyCoronary Disease
Seung-Jung Park 238
Large-scale testing (Phase 3)Looking for participantsNCT04319627
What this trial is testing

Statins for Venous Event Reduction in Patients With Venous Thromboembolism

Who this might be right for
Venous ThromboembolismBlood ClotPost Thrombotic Syndrome
Ottawa Hospital Research Institute 2,700
Post-approval studies (Phase 4)Not Yet RecruitingNCT07602257
What this trial is testing

Investigating a Personalized Approach to Anti-Platelet Therapy

Who this might be right for
High Risk Bleeding
Ottawa Heart Institute Research Corporation 1,760
Next Page